This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Magellan Launches Total Drug SolutionsSM Offering Complete Drug Management

Stocks in this article: MGLN

Magellan Pharmacy Solutions, a subsidiary of Magellan Health Services Inc. (NASDAQ: MGLN), announced today the launch of Total Drug Solutions SM, a revolutionary integrated approach to managing all drugs – oral, injectable and infusible – to improve the quality and safety of care while lowering costs for consumers and health plans.

“Historically, patients have received standard medications and specialty drugs in a disconnected and uncoordinated fashion. This lack of integration presents safety risks, decreases therapeutic effectiveness and unnecessarily increases costs,” said Tina Blasi, president of Magellan Pharmacy Solutions.

“Payers have managed traditional pharmaceutical costs to a flat trend. However, specialty drug spending has increased dramatically . With recent advances in pharmaceutical technology, patients and payers need better support to coordinate treatment, manage costs and ensure patients achieve the best outcomes.

Total Drug Solutions combines our strengths in both specialty and medical drug management with our experience in traditional pharmacy benefit solutions to provide a patient-centric, 360-degree approach to drug management. Our philosophy is to help patients receive the right drug in the right amount at the right place.”

Magellan has launched a new website,, where health plans, employers and government agencies can learn more about the Total Drug Solutions suite of services. Evidence-based drug utilization tools ensure that coverage decisions are consistently applied across both medical and pharmacy benefits, reducing the variability of care. Magellan has enhanced its proprietary web-based utilization management system to empower providers with evidence-based information and decision support for all drugs.

“Our customers recognize that the true value comes in incorporating our specialty and medical pharmacy experience into these integrated, comprehensive services,” said Blasi.

“We combine this ‘total drug’ approach with a deep understanding of the most dynamic, and most difficult to manage, components of drug benefit management, such as utilization management in the physician practice and site-of-service management. This unrivaled breadth of experience and expertise will allow us to customize solutions to meet the changing needs of our customers.”

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs